Question 1

What is the catalog number for PLLA10000-PEG2000-VS?

Accepted Answer

The catalog number for PLLA10000-PEG2000-VS is TCL-00569.

Question 2

What sizes are available for PLLA10000-PEG2000-VS?

Accepted Answer

PLLA10000-PEG2000-VS is available in the following size(s): 100 mg, 250 mg, 50 mg.

Question 3

How many pack sizes does PLLA10000-PEG2000-VS come in?

Accepted Answer

PLLA10000-PEG2000-VS is available in 3 different pack sizes.

Question 4

Is PLLA10000-PEG2000-VS in stock?

Accepted Answer

PLLA10000-PEG2000-VS is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

Who manufactures PLLA10000-PEG2000-VS?

Accepted Answer

PLLA10000-PEG2000-VS is manufactured by Molfinity.

Question 6

What is the estimated delivery time for PLLA10000-PEG2000-VS?

Accepted Answer

Estimated delivery time for PLLA10000-PEG2000-VS is approximately 10 business day(s), depending on your location.

Question 7

What documentation should I request if this product is used for a regulated or intellectual-property-sensitive application?

Accepted Answer

If the product is subject to intellectual property protections, we’ll advise on any MTA or usage restrictions before shipping. Let us know your intended end use so we can confirm what’s required upfront.

Question 8

Is this antibody conjugated?

Accepted Answer

Conjugation status, such as unconjugated, HRP, FITC, or biotin, is specified in the product name and confirmed on the datasheet.

Question 9

What is the sensitivity of this ELISA kit?

Accepted Answer

Assay sensitivity, including the minimum detectable dose, is listed on the datasheet. Kits that are assembled on order typically ship within 2-4 weeks.

PLLA10000-PEG2000-VS

Product Specifications

Bioactivity

Shipping Conditions

Storage Temperature

Available Sizes

Frequently Asked Questions

Explore Other Products

FAM171A1 (Protein FAM171A1, Family with Sequence Similarity 171, Member A1)

STK3 Antibody

STK3 Antibody

STK3 Antibody

Anetumab Biosimilar - Anti-MSLN mAb - Research Grade

Anetumab Biosimilar - Anti-MSLN mAb - Research Grade